Table 1.
Basic and metabolic parameters.
Butyrate (n = 12) |
Donor FMT (n = 12) |
||||||
---|---|---|---|---|---|---|---|
Before | After | P | Before | After | P | ∗P | |
BMI, kg/m2 | 34.3 ± 3.4 | 34.2 ± 3.7 | 0.76 | 33.0 ± 3.5 | 33.1 ± 3.4 | 0.35 | 0.36 |
Fasting glucose, mmol/l | 6.1 [5.7–6.3] | 5.7 [5.4–6.5] | 0.23 | 5.6 [5.2–5.8] | 5.5 [5.0–5.9] | 0.281 | 0.54 |
Fasting insulin, pmol/l | 70 [59–114] | 61 [48–96] | 0.25 | 77 [53–105] | 66 [62–83] | 0.169 | 0.81 |
HbA1c, mmol/l | 40 [35–45] | 37 [34–44] | 0.04 | 37 [34–39] | 35 [33–38] | 0.04 | 0.41 |
Cholesterol | |||||||
|
5.5 ± 1 | 5.1 ± 0.8 | 0.04 | 5.9 ± 1.2 | 5.6 ± 1 | 0.09 | 0.85 |
|
3.5 [2.6–4.3] | 3.2 [2.8–4] | 0.14 | 3.9 [3.1–4.5] | 3.7 [2.8–4.2] | 0.27 | 0.72 |
|
1.4 [1.2–1.6] | 1.4 [1.2–1.5] | 0.55 | 1.6 [1.3–1.8] | 1.4 [1.2–1.6] | 0.05 | 0.26 |
|
1.4 [1.1–1.7] | 1.2 [0.9–1.4] | 0.03 | 1.2 [0.8–1.5] | 1.3 [0.9–1.4] | 0.84 | 0.11 |
Glucose Rd, umol/kg.min | 38.5 [30.8–47.4] | 38.1 [27.5–42.9] | 0.21 | 38.1 [33.4–53.2] | 39.9 [27.9–45.9] | 0.21 | 0.32 |
EGP suppression, % | 74.8 [64.8–82.4] | 79 [70.2–86.7] | 0.87 | 82.7 [75.7–97.3] | 91.2 [73.8–99.7] | 0.34 | 0.81 |
REE, kcal/day | 1761 ± 259 | 1738 ± 210 | 0.56 | 1694 ± 220 | 1673 ± 205 | 0.63 | 0.91 |
Glycerol Ra suppression, % | 66.6 [63.4–69.6] | 68.6 [47.8–74.4] | 0.58 | 64.7 [56.8–67.6] | 53.5 [44.8–67] | 0.31 | 0.60 |
FFA suppression, % | 89.6 ± 4.9 | 86.9 ± 5.9 | 0.09 | 89.3 ± 7.7 | 90.1 ± 5.2 | 0.68 | 0.15 |
IHTG, % | 4.7 [2.8–11.1] | 4.3 [3.5–12.0] | 0.91 | 5.8 [3.9–12.9] | 6.1 [3.3–11.8] | 0.59 | 0.77 |
CRP, mg/ml | 2.5 [2.9–5.0] | 1.7 [0.9–4.6] | 0.38 | 2.1 [0.9–3.1] | 3.2 [1.0–5.2] | 0.13 | 0.10 |
Creatinine, μmol/l | 76 ± 12 | 76 ± 11 | 0.82 | 75 ± 14 | 74 ± 13 | 0.67 | 0.66 |
SBP, mmHg | 134 [100–141] | 128 [124–141] | 0.35 | 126 [115–140] | 119 [111–138] | 0.69 | 0.45 |
DBP, mmHg | 72 [60–75] | 70 [65–77] | 0.43 | 73 [66–75] | 68 [63–78] | 0.209 | 0.25 |
MAP, mmHg | 95 [76–98] | 91 [87–102] | 0.34 | 91 [85–103] | 85 [82–102] | 0.34 | 0.22 |
HR, beats/min | 61 [56–67] | 58 [55–63] | 0.12 | 62 [60–70] | 63 [59–66] | 0.93 | 0.16 |
CO, l/min | 5.5 [5.2–6.1] | 6 [4.9–6.3] | 0.53 | 5.5 [5.1–6.1] | 5.5 [5.4–6] | 0.21 | 0.48 |
SDNN, millisecond | 44 [34–55] | 64 [50–73] | 0.01 | 49 [41–57] | 54 [40–70] | 0.53 | 0.13 |
Compliance, number of capsules not taken | 0 | 0 | 0 | 0 |
Data are expressed as mean ± SD or median [IQR]. ∗p = change over time between groups. A p value < 0.05 was considered statistically significant. BMI = body mass index, HbA1c = glycated hemoglobin, HDL = high-density lipoprotein, HOMA-IR = homeostatic model assessment of insulin resistance, LDL = low-density lipoprotein, CRP = c-reactive protein, SBP = systolic blood pressure, DBP = diastolic blood pressure, EGP = endogenous glucose production, Rd = rate of disappearance (insulin sensitivity), Ra = rate of appearance, FFA = free fatty acid, REE = resting energy expenditure, IHTG = intrahepatic triglyceride, MAP = mean arterial pressure, HR = heart rate, CO = cardiac output, SDNN = standard deviation of the normal-to-normal intervals (inter-beat intervals derived from continuous blood pressure recordings after filtering).